688382

InventisBio
688382

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥18.98B
EV
CN¥17.37B
Shares Outstanding
578.33M
Beta
0.45

Wall Street View

Analyst Rating
BUY
Analyst Target Price
CN¥28.50
P/E 2025E
-
P/Revenue 2025E
87.82x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About InventisBio Co., Limited

gainify
688382

InventisBio Co., Limited

688382

InventisBio Co., Limited, a clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States. The company’s drug candidates for the oncology therapeutic area include BPI-D0316, wh...

Sector

Industry

CEO

Wang, Yaolin

Employees

185

IPO Date

Headquarters

No.4, Libing Road, Room 210, Lane 67, Pudong, Shanghai Province, 201203, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.